M207AN : Host-directed Therapy for Tuberculosis

The current conventional therapy for Tuberculosis, Mycobacterium tuberculosis infection, consists of at least four antibiotics taken for six months, with poor tolerance and significant side effects. By modulating our immune system, WARS1 combined with antimycobacterial agents can efficiently eradicate Mtb over a shorter period of time without adverse effects.